| Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325) |
|---|
| 09/21/2006 | WO2006060737A3 Mitotic kinesin inhibitors |
| 09/21/2006 | US20060211866 Process for the preparation of angiotensin receptor blockers and intermediates thereof |
| 09/21/2006 | US20060211675 Preventives/remedies for urinary disturbance |
| 09/21/2006 | CA2602609A1 Novel anthranilic acid derivative or salt thereof |
| 09/21/2006 | CA2600508A1 Arylsulfonyl benzyl ethers as 5-ht2a antagonists |
| 09/20/2006 | EP1554253A4 Imidazolium cxcr3 inhibitors |
| 09/20/2006 | CN1835927A Inhibitors of cathepsin S |
| 09/20/2006 | CN1834611A Cyanogen-less hemolysin for blood cell analyzer and prepn. method |
| 09/20/2006 | CN1834090A Benzimidazole compounds, its prepn. and uses |
| 09/14/2006 | WO2006096584A1 Process for the preparation of substituted benzoxazole compounds |
| 09/14/2006 | US20060205952 Aminocarbonyl naphthol derivative, cyanonaphthol derivative, and method for producing them |
| 09/14/2006 | US20060205942 2-(2-Hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors |
| 09/14/2006 | US20060205803 1,2 Diarylbenzimidazoles and their pharmaceutical use |
| 09/14/2006 | US20060205802 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 09/14/2006 | US20060205785 Fused ring compounds substituted with a 8-azabicyclo[3.2.1]octane(cyclo)alkylene group, including benzothiazolones, e.g., 3-[3-(3-Propyl-8-aza-bicyclo[3.2.1]oct-8-yl)-propyl]-3H-benzothiazol-2-one; highly selective muscarinic agonists, particularly for the M1 and/or M4 receptor subtypes |
| 09/14/2006 | US20060205744 Fused heterocyclic derivatives as ppar modulators |
| 09/14/2006 | CA2601973A1 Process for the preparation of substituted benzoxazole compounds |
| 09/13/2006 | EP1699765A1 Process for preparing telmisartan |
| 09/13/2006 | EP1699455A1 Heterocyclic aspartyl protease inhibitors |
| 09/13/2006 | EP1699453A1 Cyclic guanidines, compositions containing such compounds and methods of use |
| 09/13/2006 | EP0917462B1 Cell adhesion inhibitors |
| 09/13/2006 | CN1832742A Nitrooxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-ii receptor blockers for the treatment of cardiovascular diseases |
| 09/13/2006 | CN1274670C Diaminopropionic acid derivatives |
| 09/12/2006 | US7105530 Pyrimidineamines as angiogenesis modulators |
| 09/12/2006 | CA2307037C Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production |
| 09/12/2006 | CA2140929C Hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 09/08/2006 | WO2006094236A1 N-phenyl benzamide derivatives as sirtuin modulators |
| 09/08/2006 | WO2006094235A1 Fused heterocyclic compounds and their use as sirtuin modulators |
| 09/08/2006 | CA2599989A1 N-phenyl benzamide derivatives as sirtuin modulators |
| 09/08/2006 | CA2599987A1 Fused heterocyclic compounds and their use as sirtuin modulators |
| 09/07/2006 | US20060199838 3-hydroxy-N-(3-hydroxy-4-methoxyphenyl)-4-methoxybenzamide, used in the treatment of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyloidosis, such as observed non-insulin depepndent diabetes |
| 09/07/2006 | US20060199822 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 09/07/2006 | US20060199799 Benzimidazolidinone derivatives as muscarinic agents |
| 09/06/2006 | EP1698629A2 Polyamines and their use in therapy |
| 09/06/2006 | EP1697350A1 Tricyclic steroid hormone nuclear receptor modulators |
| 09/06/2006 | EP1697292A1 Method for the production of tetrahydrogeranylacetone |
| 09/06/2006 | EP1696915A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 09/06/2006 | EP1458673B1 Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar) |
| 09/06/2006 | EP1409490B1 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta a|naphthalenyl derivatives with antipsychotic activity |
| 09/06/2006 | EP1383768B1 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 09/06/2006 | EP1135374B1 Benzimidazole compounds that are vitronectin receptor antagonists |
| 09/06/2006 | CN1827619A Pyrimidine-5-(1H)-ketone derivative |
| 09/06/2006 | CN1273128C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides |
| 09/05/2006 | US7102012 Process for preparing N,N'-carbonyldiazoles |
| 09/05/2006 | US7101994 Process for preparing substituted benzimidazole compounds |
| 08/31/2006 | WO2006089927A1 Method for obtaining a pharmaceutically active compound (irbesartan) and its synthesis intermediate |
| 08/31/2006 | WO2006066133A3 Histone deacetylase inhibitors |
| 08/31/2006 | US20060194969 4-Substituted benzimidazoles and their uses as inhibitors of gastric secretion |
| 08/31/2006 | US20060194859 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity |
| 08/31/2006 | US20060194857 Anti-diabetic activity, improves insulin resistance and control the blood glucose level more safely, simulates activity of peroxisome proliferator-activated receptor; (1-{(2E)-3-[3-(Bromomethyl)phenyl]prop-2-en-1-yl}-1H-pyrrol-2-yl)(4-methyl-phenyl)methanone |
| 08/31/2006 | US20060194817 N-{(1S,2R)-1-(3,5-difluorobonzyl)-2-hydroxy-3-[(3-iodobonzyl)amino]propyl}-2-{4-[(methylsulfonyl)amino]phenyl}acetamide; inhibitors of the beta- secretase enzyme useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mamma |
| 08/31/2006 | US20060194805 Capsaicin receptor agonists |
| 08/30/2006 | EP1694640A1 Anti-cancer agents |
| 08/30/2006 | EP1694638A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 08/30/2006 | EP1543002B1 Preparation of 1h-imidazo 4,5-c|quinolin-4-amines via1h-imidazo 4,5-c|quinolin-4-phthalimide intermediates |
| 08/30/2006 | CN1826325A 4,5-dihydro-imidazole as P2X7 ion channel blockers |
| 08/30/2006 | CN1824655A Method of controlling polymer molecular weight and structure |
| 08/30/2006 | CN1272333C 2-pyridyl-1H-benzimidazole-4-amide derivatives |
| 08/30/2006 | CN1272325C Prepn of 1-((2-cyanobiphenyl-4-radical)methyl)-2-ethoxylbenzimidazole-7- ethyl formate as candixatan ester intermediate |
| 08/29/2006 | US7098215 Nitrogenous compounds and antiviral drugs containing the same |
| 08/29/2006 | US7098202 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 08/29/2006 | CA2396738C Thiazole derivatives as active superoxide radical inhibitors |
| 08/24/2006 | WO2006088140A1 Phthalocyanine compound, process for producing the same, and colored composition containing the phthalocyanine compound |
| 08/24/2006 | WO2006066126A3 Phenol-heterocyclic ligands, metal complexes, and their uses as catalysts |
| 08/24/2006 | WO2006001958A3 Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity |
| 08/24/2006 | US20060189674 Deacetylase inhibitors |
| 08/24/2006 | US20060189647 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof |
| 08/24/2006 | US20060189629 N-(2-morpholin-4-ylethyl)-1-(4-{[4-(trifluoromethoxy)benzyl]oxy}phenyl)-1H -benzimidazole-5-carboxamide; c-Kit proto-oncogene (stem cell factor receptor) anhibitor; tyrosine kinase inhibitor; antiproliferative, anticarcinogenic agent; |
| 08/24/2006 | US20060189611 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 08/24/2006 | US20060189593 Aryl spirohydantoin cgrp receptor antagonists |
| 08/24/2006 | US20060189549 Chalcone derivatives and their use to treat diseases |
| 08/23/2006 | EP1692124A1 Biaryl sulfonamides as mmp inhibitors |
| 08/23/2006 | EP1692114A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 08/23/2006 | EP1692113A1 Aryl imidazoles and their use as anti-cancer agents |
| 08/23/2006 | EP1558612B1 Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same |
| 08/23/2006 | EP1401836B1 Imidazo¬1,2-a|pyridine derivatives for the prophylaxis and treatment of herpes viral infections |
| 08/23/2006 | EP0837052B1 Bicyclic amino derivatives and pgd 2 antagonist containing the same |
| 08/23/2006 | CN1823072A Inhibitors of P38 and methods of using the same |
| 08/23/2006 | CN1823068A Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 08/23/2006 | CN1823064A 2-arylamino-pyrimidines for the treatment of GSK3-related disorders |
| 08/23/2006 | CN1823062A Sulfonyldihydro- benzimidazolone compounds as 5-hydroxytryptamine-6 ligands |
| 08/23/2006 | CN1821229A Processes for preparing benzo[b]thiophene derivatives |
| 08/23/2006 | CN1271059C Cyano substituted heterocyclic ketene semiamine contained molecular material and its preparation method |
| 08/22/2006 | US7094911 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 08/22/2006 | US7094905 Forming biotin |
| 08/22/2006 | US7094801 Inhibiting the expression of VCAM-1; treating inflammatory disorders including rheumatoid arthritis, atherosclerosis, COPD, asthma, allergic rhinitis and restinosis |
| 08/22/2006 | US7094790 containing a pyrrole ring, e.g., 4-{2-[2-(2-(R)-Methyl-pyrrolidin-1-yl)-ethyl]-benzothiazol-5-yl}-benzonitrile; useful for treating conditions and disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight. |
| 08/22/2006 | US7094784 High affinity ligands for nociceptin receptor ORL-1 |
| 08/17/2006 | WO2006086705A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists |
| 08/17/2006 | WO2005107762A3 Certain chemical entities, compositions, and methods |
| 08/17/2006 | US20060183784 Human growth hormone antagonists |
| 08/17/2006 | US20060183737 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists |
| 08/17/2006 | CA2598429A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists |
| 08/17/2006 | CA2594657A1 Inhibitors of checkpoint kinases |
| 08/17/2006 | CA2592320A1 Methods and compositions for treating amyloid-related diseases |
| 08/16/2006 | EP1690855A1 Process for the preparation of phenylene-bis-benzimidazol-tetrasulfonic acid disodium salt |
| 08/16/2006 | EP1689716A1 Biaryl sulfonamides and methods for using same |
| 08/16/2006 | EP1689380A2 Method for treating adamts-5-associated disease |
| 08/16/2006 | EP1252160B1 Methanocarba cycloalkyl nucleoside analogues |
| 08/16/2006 | EP1198233B1 Sulfonamide and sulfamide substituted imidazoquinolines |